Concord Drugs Ltd

Concord Drugs Ltd | Sector: Pharmaceuticals | ISIN: INE858L01010

KEY RATIOS

No Record Found

Corporate Actions

02 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Feb , 2023

12:00 AM

03 Nov , 2022

12:00 AM

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Sep , 2022

12:00 AM

AGM

Announcement date: 08 Sep , 2022

View Details

03 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Aug , 2022

12:00 AM

13 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Aug , 2022

12:00 AM

28 Jul , 2022

12:00 AM

28 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2022

12:00 AM

06 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Sep , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 02:15 PM

PROMOTER - TOTAL49.00%

Indian: 49.00%

Foreign: 0%

NON-PROMOTER - TOTAL 51.00%

Institutions: 0.00%

Non-Institutions: 51.00%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Concord Drugs Ltd News and Update

Image not found
  • 7 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

No Data Available To Display Chart

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Concord Drugs Ltd

  • S Nagi Reddy

  • Chairman & Managing Director
  • K Ramchandra Reddy

  • Independent Director
  • Koni Reddy

  • Whole Time Director & CFO
  • S. Nagavenkata Hareesh

  • Independent Director
  • S. Manoj Kumar Reddy

  • Whole-time Director
  • Summela Kasu

  • Independent Director